2014

Global Generics Strategy - Key Drivers, Markets and Trends for Pharmaceutical Companies

FARMINGTON, Conn., April 17, 2013 /PRNewswire-iReach/ -- Generic manufacturing has become increasingly crucial in the present economic climate due to various factors that have necessitated the reduction of healthcare expenditures. Financial austerity in Europe, slowed economic growth in the US, a growing aging population, and an associated increase in the demand for healthcare, are some of the key drivers responsible for governments initiatives aimed at drastically reducing their healthcare spending. Pharmaceutical companies are often the parties on the receiving end of these price cuts, while generic manufacturers reap the benefits, as their products enjoy improved sales as a result of these initiatives.

(Logo: http://photos.prnewswire.com/prnh/20130417/CG95822)

Generic manufacturers have been quick to capitalize on the misfortunes of their branded pharmaceutical counterparts by increasing their Abbreviated New Drug Application (ANDA) filings in a bid to capture market share in the highly competitive global pharmaceuticals space. The branded versions of Tevas 147 product registrations awaiting FDA approval at the end of January 2013, collectively generated sales of over $91 billion for their originator companies in 2012. This further reaffirms the strategic positioning of generic manufacturers in the current pharmaceutical landscape.

PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013

This report identifies the key generic players in various pharmaceutical markets, including a special focus on emerging markets such as India, China, Russia, and Brazil. Key trends, significant M&A deals, and the operations strategy of these companies are described and captured by the report.

More information about this report and a free sample are available at http://www.giiresearch.com/report/gd267066-pharmasphere-global-generics-strategy-key-drivers.html

PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013

This report compares the competitive position of 30 generic pharmaceutical companies across various markets on 12 financial metrics. The performances of these companies are analyzed based on financial performance, cost-containment, capital structure, and efficiency to illustrate the different strategies these companies are using to increase shareholder value and capture market share from branded pharmaceuticals manufacturers. In addition to the financial metrics, this report presents SWOT analyses of the major players, and describes the operations strategy of these companies.

More information about this report and a free sample are available at http://www.giiresearch.com/report/gd267065-pharmaleaders-generic-manufacturers-benchmark.html

Find more market research for the generic drugs industry

With nearly 30 years of market research experience, Global Information, Inc (GII) is the single best resource for companies entering new markets, expanding their business, and securing their positions in their respective industries. With tens of thousands of reports from over 400 publishers in nearly every vertical market, our market research and forecast data can give companies the edge they need to stay ahead of the competition and plan for every contingency.

The reports above are just a few examples from the hundreds of research reports we have available for the generic drugs market. For a free consultation on the market research you need, contact us today!

Recommended conference:

World Pharma Congress 2013

June 4 – 7, 2013 | Philadelphia, USA

After a dozen years, covering various topics for the pharmaceutical industry, the World Pharma Congress has found its niche in effectively covering the latest preclinical strategies and technologies for driving better predictions. Building on its experience covering drug targets, high-throughput screening, lead optimization, ADME and drug safety, the event is now primed to move further downstream into early formulations and drug delivery.

Register by April 19, 2013 and save up to $200. For more information, visit http://www.giiconference.com/chi253345-2013/

Event Organizers: Need to reach biotech, pharmaceutical, and healthcare executives in Asia?

For over a decade, Global Information Inc, through our GlobalReach event service, has connected conference and event organizers in the West with attendees, exhibitors, and sponsors in the East. Offering affordable fixed-price translation, localization, and conference marketing services, GlobalReach is bridges the gap between cultures to connect organizers with the fastest growing markets on the planet. Visit our website or contact us today to learn more.

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information, Inc.



RELATED LINKS
http://www.giiresearch.com

More by this Source

View all news by Global Information, Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.